Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Garry Box"'
Autor:
Robert Brown, Stanley B. Kaye, David L. Hudson, Garry Box, Craig P Carden, Ian Titley, Louisa Luk, Daniel Liber, Alessandra Santos-Silva, Wei Dai, Paul Mellor, Jenny M. Hersey, Siân Rizzo
Supplementary Table 1 from Ovarian Cancer Stem Cell–Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bfdec21618bcf0f5568ae2f5dfdeddd
https://doi.org/10.1158/1535-7163.22496746
https://doi.org/10.1158/1535-7163.22496746
Autor:
Robert Brown, Stanley B. Kaye, David L. Hudson, Garry Box, Craig P Carden, Ian Titley, Louisa Luk, Daniel Liber, Alessandra Santos-Silva, Wei Dai, Paul Mellor, Jenny M. Hersey, Siân Rizzo
Supplementary Table 2 from Ovarian Cancer Stem Cell–Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42d31355882021f2be82866e47eb8296
https://doi.org/10.1158/1535-7163.22496743.v1
https://doi.org/10.1158/1535-7163.22496743.v1
Autor:
Robert Brown, Stanley B. Kaye, David L. Hudson, Garry Box, Craig P Carden, Ian Titley, Louisa Luk, Daniel Liber, Alessandra Santos-Silva, Wei Dai, Paul Mellor, Jenny M. Hersey, Siân Rizzo
Platinum-based chemotherapy, with cytoreductive surgery, is the cornerstone of treatment of advanced ovarian cancer; however, acquired drug resistance is a major clinical obstacle. It has been proposed that subpopulations of tumor cells with stem cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ea5b177caa2cfe877dbe12141d550ff
https://doi.org/10.1158/1535-7163.c.6535381
https://doi.org/10.1158/1535-7163.c.6535381
Autor:
Robert S. Brown, Siân Rizzo, Alessandra Santos-Silva, Jenny M. Hersey, Craig P. Carden, Daniel Liber, Wei Dai, Garry Box, David Hudson, Louisa Luk, Stanley B. Kaye, Paul Mellor, Ian Titley
Publikováno v:
Molecular Cancer Therapeutics. 10:325-335
Platinum-based chemotherapy, with cytoreductive surgery, is the cornerstone of treatment of advanced ovarian cancer; however, acquired drug resistance is a major clinical obstacle. It has been proposed that subpopulations of tumor cells with stem cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae0be77784c6964fbb69427f3c118ea7
https://doi.org/10.1158/1535-7163.mct-10-0788
https://doi.org/10.1158/1535-7163.mct-10-0788
